Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients

Abstract Background Prolyl 4-hydroxylase subunit beta (P4HB) has been reported as a suppressor in ferroptosis. However, no known empirical research has focused on exploring relationships between P4HB and prostate cancer (PCa). In this research, we initially examine the function of P4HB in PCa by tho...

Full description

Bibliographic Details
Main Authors: Dechao Feng, Li Li, Dengxiong Li, Ruicheng Wu, Weizhen Zhu, Jie Wang, Luxia Ye, Ping Han
Format: Article
Language:English
Published: BMC 2023-07-01
Series:European Journal of Medical Research
Subjects:
Prolyl 4-hydroxylase subunit beta
Prostate cancer
Radiotherapy resistance
Cell proliferation
Ferroptosis
Online Access:https://doi.org/10.1186/s40001-023-01215-2

Internet

https://doi.org/10.1186/s40001-023-01215-2

Similar Items